Search PubMed⌕ Search

Biomedical subjects

E Vano

Publications and source records attributed to E Vano.

27 records · Page 2Linked to original sources
PubMed2003

Patient surface radiation doses at two PET imaging facilities.

To develop a practical means of auditing the procedures and to optimize the administered radionuclide activity, patient surface radiation doses following the administration of 18FDG for PET imaging have been measured at breast and gonad locations at two PET facilities. Patient dosimetry was performed using LiF TLD-100 chips placed near the breasts and gonads for 2 h following tracer injection. Standard uptake values from the image-reconstruction algorithms of one PET camera were investigated in regions of interest in tomograms of the myocardium and liver with the aim of validating dosimetry at breasts. Mean doses measured on the patient's skin ranged between 3.3 and 6.1 microGy MBq(-1) at the gonads and between 3.9 and 6.4 microGy MBq(-1) at the breasts, noticeably lower than the calculations reported in the literature. These values show good concordance with the injected activities, although they are not proportional. The proportion of injected activity actually contributing to image production seems to decrease gradually as the injected activity increases. Conversely, for a given injected activity, breast and gonadal doses were found to be lower than the values expected from the numerical calculations reported in the literature, showing increasing discrepancies when the injected activity increased. Doses measured at the right breast were consistently higher than for the left, which is indicative of greater radiotracer absorption by the liver compared to the average absorption in the body.

Adult↗
PubMed2003

Skin dose and dose-area product values in patients undergoing intracoronary brachytherapy.

Entrance skin doses, dose-area product (DAP) values, fluoroscopy times and digital cine acquisition data were measured for 86 patients undergoing intracoronary brachytherapy procedures with beta sources, to estimate risk of skin injuries. Interventions were carried out in three dedicated X-ray interventional cardiology rooms equipped with X-ray systems operating in pulsed modes, with high filtration and edge filter options. Skin dose distribution was analysed in detail in 56 patients using slow films and thermoluminescent dosimetry. Digital recording of Digital Imaging and Communications in Medicine cine images also allowed analysis of the technical parameters used throughout the procedures. A protocol for clinical follow-up of these patients at the cardiology service is also presented, which prescribes special attention when a threshold dose is reached. Median values for DAP, fluoroscopy time and number of frames were 81.2 Gy cm(2), 17.5 min and 1569 frames, respectively, and maximum values were 323.3 Gy cm(2), 46.2 min and 3213 frames, respectively. In two cases, maximum skin doses in a procedure reached 3.5 Gy and 4.6 Gy. Comparing median values in this study, intracoronary brachytherapy involved approximately two-fold the DAP used in percutaneous transluminal coronary angioplasty procedures performed during the same period in the same catheterization laboratories, as a consequence of the need to monitor the radioactive source location used for the treatment of stenoses and the intravascular ultrasound. Special care must be paid in those cases of high dose in relation to potential patient skin injuries and late effects.

Brachytherapy↗
PubMed2003

Short communication: Practical aspects for the evaluation of skin doses in interventional cardiology using a new slow film.

Mapping skin doses in complex fluoroscopy interventions is useful to determine the probability of a possible injury, to detect areas of overlapping irradiation fields and to obtain a permanent register of the most exposed patient skin areas. To fulfil this task, large films with slow X-ray response can be used. Recently, Kodak has introduced a new radiotherapy verification film, named EDR2 (Extended Dose Range). The aim of this paper is to analyse the possibilities of using this new film for estimating skin dose distributions in interventions with potentially higher doses, such as complex percutaneous transluminal coronary angioplasty (PTCA), intravascular brachytherapy procedures (IVB) or cardiac ablations. The EDR2 film by Kodak is an improved option to be used in interventional cardiology to obtain maps of patient skin doses and to estimate maximum skin doses up to 1400 mGy. Film kVp dependence is negligible and the processor conditions can be standardized to obtain skin dose estimations. The linear range for accurate dose measurements is from 50 mGy to 500 mGy.

Angioplasty, Balloon, Coronary↗
PubMed2003

Patient dose values in a dedicated Greek cardiac centre.

The purpose of this study was to collect information on the practice and patient doses in a major Greek cardiac centre, investigate differences between senior cardiologists of various levels of experience and compare results with the literature, in order to optimize angiographic and interventional cardiology procedures. Radiation doses from 292 patients have been studied, 195 of which had undergone coronary angiography and 97 percutaneous transluminal coronary angioplasty. All procedures were undertaken on a Siemens Angioscop X-ray equipment. The system performed under automatic exposure control using pulsed fluoroscopy of 12.5 pulses s(-1) and cine frame rate of 25 frames s(-1). Dose-area product values, fluoroscopy times, total number of cine frames as well as operator's name were collected for each patient. Only senior cardiologists have participated in the study. Median values for dose-area product were 39.1 Gy cm(2) for coronary angiography and 58.3 Gy cm(2) for percutaneous transluminal coronary angioplasty. Median fluoroscopy time was 5.0 min and 9.7 min and median number of frames was 1588 and 1823 for coronary angiography and percutaneous transluminal coronary angioplasty, respectively. Comparison showed that patient dose-area product values were lower than other studies and fluoroscopy time values were comparable. However, the total number of frames used was much higher than other published results. Differences between cardiologists with increased experience have been found. Analysis of the patient dose values obtained initiated a program of radiation protection optimization. The need for continuous training in radiation protection for interventionalists has been verified.

Adult↗
PubMed2001

Skin dose and dose-area product values for interventional cardiology procedures.

Coronary angiography and percutaneous transluminal coronary angioplasty procedures performed in four different facilities were monitored in the present study by measuring maximum skin dose, dose-area product and other operational parameters. Radiographic slow film, thermoluminescent dosemeters and transmission ion chambers were used to measure dose related quantities. Values of 107-711 mGy for maximum skin dose and 27.3-370.6 Gy cm2 for dose-area product were found, together with cumulative skin dose estimates of 110-3706 mGy. A discussion of the relationship of measured dose-area product and skin dose values is made using a field concentration factor defined as a way to interpret the findings. No general correlation was observed between dose-area product and maximum skin dose. Cumulative skin dose estimates throughout a procedure should be discarded as a realistic method for assessing deterministic risk in cardiology procedures. Slow film in addition to thermoluminescent dosemeters for measurement of maximum skin dose is a good alternative, especially for complex interventional procedures. For repeated procedures, combining film and dose-area product monitoring favours optimization of radiation protection for the patient.

Angioplasty, Balloon, Coronary↗
PubMed2001

Skin radiation injuries in patients following repeated coronary angioplasty procedures.

This study investigates the incidence of skin injuries and retrospectively estimates skin doses in a sample of patients who had multiple coronary angiographies and who underwent more than four percutaneous transluminal coronary angioplasties (PTCAs), performed primarily by the same team of cardiologists in a university hospital. A database of 7824 PTCAs performed during the last 14 years was analysed. Patients were selected and reviewed by a cardiologist and two radiotherapists with experience in radiation-induced skin injuries. A retrospective analysis of skin doses was performed using data from the patients' files and from the quality assurance (QA) programme of the hospital, which includes periodic patient dose measurements. 14 patients were included in the study. Each patient had undergone between 4 and 14 coronary angiographies and between 5 and 10 PTCAs, performed over a period of 2-10 years. The estimated mean dose-area product per procedure was 46 Gy cm(2) for coronary angiography and 82 Gy cm(2) for PTCA. Mean values of maximum skin dose per procedure were 217 mGy for the diagnostic studies and 391 mGy for the PTCAs. Only a slight radiation skin injury was clinically demonstrated in one patient with a history of 10 coronary angiographies and 10 PTCAs (estimated maximum skin dose 9.5 Gy). Another patient who underwent 14 coronary angiographies and 10 PTCAs (estimated maximum skin dose 7.3 Gy) showed a slight telangiectasia and discrete pigmentation. Another patient with a cutaneous lupus erythematosus showed pigmentation in the area of the radiation field following seven coronary angiographies and six PTCAs (estimated maximum skin dose 5.6 Gy), as expected bearing in mind that skin tolerance to high doses may be altered for patients with this pathology. Each of the remaining 11 patients with no skin injuries had undergone between 5 and 7 PTCAs and between 5 and 14 additional angiographies. None of the 14 patients reported acute skin injuries and no necrosis or radiodermatitis was observed.

Adult↗
PubMed1999

Radiation protection and quality assurance in diagnostic radiology--an IAEA coordinated research project in Asia and eastern Europe.

The International Atomic Energy Agency currently has two parallel Coordinated Research Projects (CRP) running in Asia and Eastern Europe. The main objective of the CRPs is to raise the level of awareness in participating countries about the need for radiation protection for patients undergoing diagnostic radiology procedures. This is to be achieved by first assessing the status quo in a sample of hospitals and X-ray rooms in each participating country. A program of optimization of radiation protection for patients is then introduced by means of a comprehensive quality assurance program and the implementation of appropriate dose reduction methods, taking into account clinical requirements for diagnostically acceptable images. Patient dose assessment and image quality assessment are to be performed both before and after the introduction of the quality assurance program. The CRP is divided into two phases--the first is concerned with conventional radiography, while the second involves fluoroscopy and computed tomography. The CRP is still running, restricting the scope of this paper to a discussion of the approach being taken with the project. The project will be completed in 1998, with analysis to follow.

Asia↗